These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1430968)

  • 41. Magnitude of drug resistant Shigellosis: a report from Bangalore.
    Srinivasa H; Baijayanti M; Raksha Y
    Indian J Med Microbiol; 2009; 27(4):358-60. PubMed ID: 19736408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of protein rich diet during acute phase of dysentery.
    Datta D; Datta P; Bhattacharya SK; Mitra U; Bhattacharya MK; Sen D; Sinna AK; Manna B; Mitra AK; Lahiri M
    Indian J Public Health; 1990; 34(1):1-5. PubMed ID: 2101381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increasing antimicrobial resistance--an emerging problem in the treatment of shigellosis.
    Niyogi SK
    Clin Microbiol Infect; 2007 Dec; 13(12):1141-3. PubMed ID: 17953700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Therapeutic effectiveness of nevigramon in the complex treatment of acute dysentery].
    Gebesh VV; Koval'chuk VK; Ianushevskaia RI; Sofienko NIa; Lysak LI
    Vrach Delo; 1980 May; (5):110-3. PubMed ID: 6994350
    [No Abstract]   [Full Text] [Related]  

  • 45. Death from multi-resistant shigellosis in Fiji Islands.
    Watson C
    Pac Health Dialog; 2001 Mar; 8(1):99-102. PubMed ID: 12017845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular epidemiological characteristics of Shigella spp. isolated from river Narmada during 2005-2006.
    Sharma A; Singh SK; Kori L
    J Environ Health; 2009; 71(6):61-6. PubMed ID: 19192746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial susceptibility of Shigella flexneri and S. dysenteriae isolated from stool specimens of patients with bloody diarrhoea in Mwanza, Tanzania.
    Temu MM; Kaatano GM; Miyaye ND; Buhalata SN; Shushu ML; Kishamawe C; Changalucha JM
    Tanzan Health Res Bull; 2007 Sep; 9(3):186-9. PubMed ID: 18087897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial resistance of Shigella spp isolated from diarrheal patients between 1989 and 1998 in Vietnam.
    Anh NT; Cam PD; Dalsgaard A
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):856-62. PubMed ID: 12041563
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nalidixic acid in Shigella dysenteriae outbreaks.
    Malengreau M
    Lancet; 1984 Jul; 2(8395):172. PubMed ID: 6146074
    [No Abstract]   [Full Text] [Related]  

  • 50. Nalidixic acid for shigellosis.
    Parry HE
    Lancet; 1983 Nov; 2(8360):1206. PubMed ID: 6139566
    [No Abstract]   [Full Text] [Related]  

  • 51. Shigella serogroups identified from adult diarrhoeal out-patients in Addis Ababa, Ethiopia: antibiotic resistance and plasmid profile analysis.
    Mache A; Mengistu Y; Cowley S
    East Afr Med J; 1997 Mar; 74(3):179-82. PubMed ID: 9185418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pharmacokinetics and clinical studies of norfloxacin in the pediatric field].
    Motohiro T; Yoshinaga Y; Tsumura N; Oki S; Sasaki H; Aramaki M; Oda K; Kawakami A; Koga T; Shimada Y
    Jpn J Antibiot; 1990 May; 43(5):901-17. PubMed ID: 2202843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial.
    Khan WA; Seas C; Dhar U; Salam MA; Bennish ML
    Ann Intern Med; 1997 May; 126(9):697-703. PubMed ID: 9139555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in children.
    Moolasart P; Eampokalap B; Ratanasrithong M
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):764-9. PubMed ID: 10928373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nalidixic acid is still the drug of choice for shigellosis in Pakistan.
    Mahmood A
    J Pak Med Assoc; 2001 Feb; 51(2):101. PubMed ID: 11321869
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparison of clinical efficacy of norfloxacin (NFLX) and pipemidic acid (PPA) in the treatment of infectious enteritis by a double-blind method. The Japan Research Committee of Norfloxacin Research Group Enteritis].
    Aoki T; Shimizu N; Tomizawa I; Takizawa Y; Matsubara Y; Seo T; Sagara H; Tagawa K; Masuda G; Negishi M
    Kansenshogaku Zasshi; 1987 Jul; 61(7):830-48. PubMed ID: 3123572
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparative efficacy of pivmecillinam and cotrimoxazole in acute shigellosis in children.
    Prado D; Liu H; Velasquez T; Cleary TG
    Scand J Infect Dis; 1993; 25(6):713-9. PubMed ID: 8052810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nalidixic acid for shigellosis.
    McCormack JG
    Lancet; 1983 Nov; 2(8358):1091. PubMed ID: 6138641
    [No Abstract]   [Full Text] [Related]  

  • 59. Problems in identification of Campylobacter jejuni associated with acquisition of resistance to nalidixic acid.
    Altwegg M; Burnens A; Zollinger-Iten J; Penner JL
    J Clin Microbiol; 1987 Sep; 25(9):1807-8. PubMed ID: 3654954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of bacillary dysentery with Wintomylon].
    Ishikawa J
    Nihon Densenbyo Gakkai Zasshi; 1967 Mar; 40(12):460-2. PubMed ID: 4962909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.